BioMarin Pharmaceutical, Inc. (BMRN)
65.07
-1.63
(-2.44%)
USD |
NASDAQ |
Aug 24, 16:00
65.04
-0.04
(-0.05%)
After-Hours: 20:00
BioMarin Pharmaceutical Market Cap : 12.59B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 12.59B |
| August 21, 2026 | 12.91B |
| August 20, 2026 | 13.10B |
| August 19, 2026 | 13.42B |
| August 18, 2026 | 12.96B |
| August 17, 2026 | 12.90B |
| August 14, 2026 | 13.04B |
| August 13, 2026 | 13.26B |
| August 12, 2026 | 13.59B |
| August 11, 2026 | 13.46B |
| August 10, 2026 | 13.33B |
| August 07, 2026 | 12.35B |
| August 06, 2026 | 11.89B |
| August 05, 2026 | 11.59B |
| August 04, 2026 | 11.75B |
| August 03, 2026 | 11.60B |
| July 31, 2026 | 11.60B |
| July 30, 2026 | 11.71B |
| July 29, 2026 | 11.86B |
| July 28, 2026 | 12.00B |
| July 27, 2026 | 11.65B |
| July 24, 2026 | 11.47B |
| July 23, 2026 | 11.38B |
| July 22, 2026 | 11.29B |
| July 21, 2026 | 11.44B |
| Date | Value |
|---|---|
| July 20, 2026 | 11.42B |
| July 17, 2026 | 11.52B |
| July 16, 2026 | 11.60B |
| July 15, 2026 | 11.39B |
| July 14, 2026 | 11.33B |
| July 13, 2026 | 11.44B |
| July 10, 2026 | 11.43B |
| July 09, 2026 | 11.59B |
| July 08, 2026 | 11.55B |
| July 07, 2026 | 11.66B |
| July 06, 2026 | 11.36B |
| July 02, 2026 | 11.40B |
| July 01, 2026 | 11.17B |
| June 30, 2026 | 11.06B |
| June 29, 2026 | 11.15B |
| June 26, 2026 | 11.40B |
| June 25, 2026 | 11.08B |
| June 24, 2026 | 11.08B |
| June 23, 2026 | 10.92B |
| June 22, 2026 | 10.80B |
| June 18, 2026 | 10.57B |
| June 17, 2026 | 10.63B |
| June 16, 2026 | 10.65B |
| June 15, 2026 | 10.76B |
| June 12, 2026 | 10.81B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 25.72B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
| Vertex Pharmaceuticals, Inc. | 138.73B |
| Ionis Pharmaceuticals, Inc. | 10.28B |
| Regeneron Pharmaceuticals, Inc. | 85.67B |
Market Cap Related Metrics
| PE Ratio | 175.44 |
| PS Ratio | 3.654 |
| Price to Book Value | 1.992 |
| Price to Free Cash Flow | 17.42 |
| Price | 65.07 |
| Earnings Yield | 0.57% |
| Operating PE Ratio | 19.75 |
| Normalized PE Ratio | 33.03 |